Netflix stock soars after strong subscriber gains, Oracle teams with OpenAI and SoftBank in a $500 billion AI infrastructure partnership, and Johnson & Johnson posts better-than-expected adjusted fourth-quarter earnings.

Wall Street analysts weigh in on Amazon, Nvidia, Carnival, Seagate Technology Holdings, Netflix, and Affirm Holdings.

Each investing journey is brimming with important lessons, and mine is no exception. Learning from the past can make you a more successful investor in the future. Closing the door on the old and ringing in the new year is a great time for reflection,

U.S. stock-market futures pointed to opening gains on Wednesday after Netflix posted better-than-expected results and President Donald Trump unveiled an artificial-intelligence infrastructure package.

Wall Street closed higher, with the S&P 500 index scoring an all-time high. Blowout Netflix results and plans for $500b AI investment fuel gains.

Netflix stock is surging 14% in premarket trade as the streaming service raised its 2025 outlook. Oracle stock rose 9% and Nvidia shares rose 3% after the announcement of a $100 billion AI infrastructure plan backed by President Donald Trump.

President Donald Trump's boost to AI demand hopes is outweighing fresh tariff threats on China and the EU, as earnings season rolls on.

Live Updates Netflix Nears $1,000 Per Share 5:34 pm The number to watch tomorrow will be whether Netflix breaks $1,000 per share. As of 5:35 p.m. ET, shares are trading for $995, which is up about 14.

Wall Street's indexes climbed on Wednesday, with the S&P 500 reaching record highs. Investors celebrated Netflix's subscriber boost and Trump's $500 billion AI investment plan. The technology sector led gains,

Chipmaker Nvidia has overtaken Apple (AAPL) once again to become the world's most valuable company, after the company's shares rose in Tuesday's session. Nvidia now has a market capitalisation of nearly $3.45tn (£2.79tn), compared to Apple's $3.35tn ...

Novo Nordisk shares surged on the results of a new obesity-drug study Friday. The Danish pharmaceutical giant behind Ozempic and Wegovy said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.

Upcoming earnings from Apple and Tesla are crucial, with concerns over iPhone sales and Tesla's stretched valuations. AI sector excitement, highlighted by Oracle's 17% rise, faces scrutiny on whether reality will meet high expectations.